Accueil › Maladie de Crohn › Floride › Orlando
Essais cliniques pour Maladie de Crohn à Orlando, FL
17 études pour Maladie de Crohn recherchent des participants dans et autour de Orlando (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Recrutement en coursPhase 4
- Endoscopic Research, Inc., Orlando
- Orlando Health-Orlando Regional Medical Center, Orlando
- Digestive and Liver Center of Florida, P.A., Kissimmee · à 16 mi
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Recrutement en coursPhase 3
- AdventHealth Orlando ( Site 5131), Orlando
- Endoscopic Research Inc ( Site 5061), Orlando
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Recrutement en coursPhase 2
- Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
- Clinical Research of Osceola /ID# 280593, Kissimmee · à 16 mi
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 2
- AdventHealth (Florida Hospital) Medical Group, Orlando
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Recrutement en coursPhase 2
- Endoscopic Research, Inc. /ID# 267211, Orlando
- Novum Research /ID# 278128, Clermont · à 24 mi
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Recrutement en coursPhase 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 3
- AdventHealth Orlando-Site Number: 8400070, Orlando
- Orlando Health, Inc.-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · à 16 mi
- et 1 autres
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 3
- Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 3
- Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · à 16 mi
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 2
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · à 16 mi
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Recrutement en coursPhase 4
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · à 16 mi
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Recrutement en cours
- Advent Health, Orlando
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Recrutement en coursÉtude observationnelle
- AdventHealth, Orlando
Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
Recrutement en coursPhase 4
- Digestive & Liver Center of Florida, Orlando
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 2
- Orlando Health, Inc., Orlando
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Recrutement en coursPhase 2
- Investigational Site Number: 8400007, Orlando
- Investigational Site Number: 8400017, Kissimmee · à 16 mi
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Recrutement en coursPhase 2
- Mirador Therapeutics Selected Site, Orlando
Essais pour Maladie de Crohn dans d'autres villes
- New York City, NY35 études
- Miami, FL19 études
- St. Louis, MO19 études
- Boston, MA19 études
- Cleveland, OH18 études
- Houston, TX17 études
- Atlanta, GA17 études
- Tyler, TX16 études
- San Diego, CA15 études
- San Antonio, TX15 études
- Los Angeles, CA15 études
- Colorado Springs, CO13 études
Autres études à Orlando
- Cancer du poumon non à petites cellules44 études
- Cancer métastatique29 études
- Obésité29 études
- Cancer (tous types)25 études
- Maladie d'Alzheimer25 études
- Surpoids25 études
- Diabète de type 224 études
- Cancer du sein23 études
- Colite ulcéreuse23 études
- Cancer de l'ovaire22 études
- Cancer du poumon21 études
- Cancer colorectal19 études
Source : ClinicalTrials.gov, données récupérées le 1 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.